Stockscreener 앱 받기
0.8618
5.79%
-0.053
Sutro Biopharma Inc 주식(STRO)의 최신 뉴스
Sutro Biopharma Inc. stock volume spike explainedWeekly Profit Recap & Consistent Growth Equity Picks - Newser
How Sutro Biopharma Inc. stock performs during market volatilityJuly 2025 Big Picture & Weekly Top Performers Watchlists - beatles.ru
Tools to monitor Sutro Biopharma Inc. recovery probability2025 Valuation Update & Daily Chart Pattern Signals - Newser
How to forecast Sutro Biopharma Inc. trends using time seriesJuly 2025 Intraday Action & Expert Verified Movement Alerts - Newser
Is Sutro Biopharma Inc. trending in predictive chart modelsEarnings Recap Report & Fast Entry Momentum Alerts - Newser
Will Sutro Biopharma Inc. Benefit From Sector TailwindsQuarterly Portfolio Summary & Proven Capital Preservation Tips - Newser
Volume spikes in Sutro Biopharma Inc. stock – what they meanCPI Data & Weekly Breakout Stock Alerts - Newser
Ranking Sutro Biopharma Inc. among high performing stocks via toolsJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Detecting support and resistance levels for Sutro Biopharma Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Is Sutro Biopharma Inc. stock poised for growth2025 Volatility Report & Daily Oversold Bounce Ideas - Newser
Combining price and volume data for Sutro Biopharma Inc.2025 Winners & Losers & Precise Trade Entry Recommendations - Newser
Full technical analysis of Sutro Biopharma Inc. stockMarket Trend Review & Verified Technical Signals - Newser
Chart based analysis of Sutro Biopharma Inc. trendsMarket Movers & AI Based Trade Execution Alerts - Newser
Quantitative breakdown of Sutro Biopharma Inc. recent moveQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
Pattern recognition hints at Sutro Biopharma Inc. upside2025 Pullback Review & Real-Time Stock Price Movement Reports - Newser
Real time scanner hits for Sutro Biopharma Inc. explained2025 Earnings Surprises & Verified Technical Trade Signals - Newser
Understanding Sutro Biopharma Inc.’s price movementChart Signals & Free Fast Gain Swing Trade Alerts - Newser
Visualizing Sutro Biopharma Inc. stock with heatmapsTake Profit & Risk Adjusted Buy and Sell Alerts - Newser
Has Sutro Biopharma Inc. found a price floorTrade Volume Report & High Return Stock Watch Alerts - Newser
Sutro Biopharma Inc. stock momentum explainedJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Strategies to average down on Sutro Biopharma Inc.2025 Dividend Review & Community Driven Trade Alerts - Newser
Will Sutro Biopharma Inc. Reverse From Oversold ConditionsJuly 2025 Pullbacks & Real-Time Stock Price Movement Reports - beatles.ru
What is the target price for Sutro Biopharma Inc. stockFree Growth Stock Screener - thegnnews.com
Sutro Biopharma price target lowered to $3 from $4 at Wells Fargo - TipRanks
Sutro Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Real time breakdown of Sutro Biopharma Inc. stock performanceFree Day Trading Signals With High Precision - Newser
Sutro Biopharma (NASDAQ:STRO) Stock Rating Upgraded by Wall Street Zen - Defense World
Has Sutro Biopharma Inc. formed a bullish divergenceMomentum Detection with Entry Optimization - Newser
Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Sutro Biopharma's Strategic Turnaround: A Path to Profitability Amidst Industry Challenges - AInvest
Sutro Biopharma’s Strategic Shift and Pipeline Developments: A Hold Rating Amid Transitional Phase - TipRanks
Sutro Biopharma Advances ADC Pipeline and Reports Q2 2025 Results - TipRanks
Sutro Biopharma 2025 Q2 Earnings Significant Net Loss Reduction - AInvest
SUTRO BIOPHARMA, INC. SEC 10-Q Report - TradingView
Sutro Biopharma earnings beat by $0.27, revenue topped estimates - Investing.com Canada
SUTRO BIOPHARMA Earnings Results: $STRO Reports Quarterly Earnings - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Advances Pipeline with Strategic Initiatives - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Sutro Reports 148% Revenue Growth as ADC Pipeline Expands, FDA Partnership Accelerates Development - Stock Titan
Chart overlay techniques for tracking Sutro Biopharma Inc.Low Drawdown Picks with Weekly Updates - Newser
0.22%
3.58%
자본화:
|
볼륨(24시간):